European drug agency sets out plans to publish clinical trial data from 20142012; 345 doi: http://dx.doi.org/10.1136/bmj.e8423 (Published 12 December 2012) Cite this as: 2012;345:e8423
- Rory Watson
The European Medicines Agency has set out how it intends to ensure greater access to clinical trial data. The year long process will see the new policy in force from 1 January 2014 and reflects the agency’s move towards a more proactive publication policy.1
The final route map reflects input from experts across the European healthcare system and the drug industry at a workshop in London on 22 November. The agency’s director, Guido Rasi, made clear to participants the new policy of publishing clinical trial data once the marketing authorisation …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial